Source: Virtual Congress 2021 – New insights into nontuberculous mycobacteria disease: from diagnosis to treatment



Rating:

Share or cite this content

Citations should be made in the following way:
M. Lipman (London, United Kingdom). NTM: an overview of changing epidemiology. Virtual Congress 2021 – New insights into nontuberculous mycobacteria disease: from diagnosis to treatment

Member's Comments

No comment yet.

Related content which might interest you: The changing epidemiology of CF Source: International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission Year: 2019 Pathogenicity of NTM: new developments Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge Year: 2007 COVID-19 epidemiology and prevention: Global update Source: ERS Course 2021 - COVID-19: State of the art Year: 2021 Respiratory care in different situations: an overview of the epidemiology of respiratory diseases and their (co)morbidity Source: Virtual Congress 2020 – Part II: From symptoms to diagnosis in primary care Year: 2020 Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions Source: Eur Respir J 2016; 48: 1545-1548 Year: 2016 Post-genome respiratory epidemiology: a multidisciplinary challenge Source: Eur Respir J 2004; 24: 471-480 Year: 2004 Historical overview: On the evolution of respiratory support for neonates Source: Research Seminar 2009 - The rationale and use of surfactant and continuous positive airway pressure (CPAP) in extremely low gestational age neonates (ELGANs) Year: 2009 Pulmonary non-tuberculous mycobacterial infection in patients without predisposing condition, morphological and immunological overview of a french cohort Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosis Source: Eur Respir J 2014; 43: 632-635 Year: 2013 Current portrait of LC-fILD: from epidemiology to clinico-patholo-radiological presentation and prognosis Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists Year: 2021 Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017 Year: 2017 The global epidemiology of HIV Source: Eur Respir Monogr 2014; 66: 1-11 Year: 2014 Non-pharmacological factors for the emergence of drug resistance in patients of pulmonary tuberculosis: An Indian overview Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control Source: Annual Congress 2013 –The best of TB PANNET Year: 2013 Miliary tuberculosis: a clinical review Source: Eur Respir J 2002; 20: Suppl. 38, 362s Year: 2002